Evidence map›Paper›PMID 35670875›Full record

ReviewAbdominal radiology (New York)2022

Imaging of fibropolycystic liver disease.

Kedar Sharbidre, Mohd Zahid, Sudhakar Kundapur Venkatesh, Chandra Bhati, Neeraj Lalwani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. [Clinical and pathological features of 20 cases of congenital hepatic fibrosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kedar SharbidreDepartment of Abdominal Imaging, University of Alabama at Birmingham, Birmingham, AB, USA. ksharbidre@uabmc.edu.
Mohd ZahidDepartment of Abdominal Imaging, University of Alabama at Birmingham, Birmingham, AB, USA.
Sudhakar Kundapur VenkateshDivision of Abdominal Imaging, Department of Radiology, Mayo Clinic, MN, Rochester, USA.
Chandra BhatiDepartment of Transplant Surgery, University of Maryland Medical Center, Baltimore, ML, USA.
Neeraj LalwaniDepartment of Abdominal Imaging, Virginia Commonwealth University, Richmond, VA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibropolycystic liver diseases (FLDs) make up a rare spectrum of heritable hepatobiliary diseases resulting from congenital ductal plate malformations (DPMs) due to the dysfunction of proteins expressed on the primary cilia of cholangiocytes. The embryonic development of the ductal plate is key to understanding this spectrum of diseases. In particular, DPMs can result in various degrees of intrahepatic duct involvement and a wide spectrum of cholangiopathies, including congenital hepatic fibrosis, Caroli disease, polycystic liver disease, and Von Meyenberg complexes. The most common clinical manifestations of FLDs are portal hypertension, cholestasis, cholangitis, and (in rare cases) cholangiocarcinoma. This article reviews recent updates in the pathophysiology, imaging, and clinical management of FLDs.

Indexed as

Bile Duct NeoplasmsCystsHypertension, PortalBile Ducts, IntrahepaticHumansLiverLiver CirrhosisLiver DiseasesCaroliCongenital hepatic fibrosisDuctal plateFibrocystic

Identifiers

PMID35670875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.